May 17, 2021 / 05:10PM GMT
Franklin Jarman - Goldman Sachs Group, Inc., Research Division - VP and Senior Analyst
Okay. Great. Thanks, everyone. We're moving on now to the next presentation. I'm Frank Jarman, our high-yield health care analyst here at Goldman Sachs, and I'm very pleased to have Bausch Health here with us today. Today, from Bausch, we have Paul Herendeen, who is the Executive Vice President and CFO of the company for now. And maybe just to kick things off, we're going to spend 25 or 30 minutes discussing the story.
Questions and Answers:
Franklin Jarman - Goldman Sachs Group, Inc., Research Division - VP and Senior AnalystBut to kick things off, I would like to ask you, Paul, and thank you for joining us.
But I'd like to ask you, you recently announced plans to transition from the CFO role into a new senior advisory role at the company, starting, I believe, next month, and I wanted to better understand, given there's been a lot going on on the company of late. How do you think about -- how you came to that decision? How should we think about the role at
Trustpilot
